Royalty Pharma plc
RPRX
주식 순위
#897
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
주가
$60.49
시가총액
$26.93B
변동 (1일)
-0.78%
변동 (1년)
63.43%
국가
US
거래 Royalty Pharma plc (RPRX)
카테고리
Healthcare
Royalty Pharma plc (RPRX)의 EPS
June 2026 기준 EPS TTM: $2.41
Royalty Pharma plc의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $2.41입니다. 2024년 말에는 회사의 EPS가 $1.92였으며, 이는 2023년의 EPS $2.54와 감소입니다.
Royalty Pharma plc의 EPS 기록 (2015 ~ 2026)
매년 말의 EPS
| 연도 | EPS | 변화 |
|---|---|---|
| 2026 (TTM) | $2.41 | 34.64% |
| 2025 | $1.79 | -6.61% |
| 2024 | $1.92 | -24.41% |
| 2023 | $2.54 | 2,492.43% |
| 2022 | $0.10 | -93.45% |
| 2021 | $1.49 | -42.47% |
| 2020 | $2.60 | -59.54% |
| 2019 | $6.42 | 182.80% |
| 2018 | $2.27 | 13.86% |
| 2017 | $1.99 | 113.83% |
| 2016 | $0.93 | -2.67% |
| 2015 | $0.96 | 0.00% |
유사 기업 또는 경쟁사의 EPS
| 회사 | EPS | EPS 차이 | 국가 |
|---|---|---|---|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $0.52 | -78.42% |
US
|
|
| $0.02 | -99.22% |
HK
|
